Trends & Forecasts

The increasing focus on sustainability in the pharmaceutical industry amongst CDMOs reveals the key strategies and initiatives being undertaken.

Counterfeit medicines pose a significant threat to global health. A recent study uncovers alarming facts and emphasizes the need for solutions.

Delali Attipoe at the DNDi explains why we need an R&D model attuned to the needs of forgotten patients.

As part of our 10-year anniversary special feature, Markus Kosch tells us his views on the future of pharma.

What does the future hold for pharma? Audrey Greenberg and Jon Zwinski give their views.

Anna Codina from Bruker BioSpin discusses the Biosecure Act and how outsourcing could be affected.

What trends and disruptions will shape the future of pharma? West’s Anya Harry gives her view.

The highlights of the trade show and its conference agenda - day 3

How the pharma industry can help tackle the opioid crisis and advance treatments

The highlights of the trade show and its conference agenda - day 2